ALAMEDA, Calif.–(BUSINESS WIRE)–Science Corporation, a brain-computer interface company focused on transcending the limits of biology through neural engineering, today announced the appointment of Darius Shahida as Chief Strategy Officer, effective J…
Category: News
Broadwood Partners Comments on STAAR Surgical Board Dissent on the Revised Sale to Alcon
NEW YORK–(BUSINESS WIRE)–Broadwood Partners, L.P. and its affiliates (collectively, “Broadwood,” “we,” “us” or “our”) today reacted to the proxy statement supplement filed by STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA) with respe…
Immunotherapy for Cat Allergy Shows Favorable Safety Profile
A depigmented polymerized cat allergoid is safe and generally well tolerated in patients with cat-induced allergic rhinitis, a real-world study finds. Medscape Medical News
Is Tirzepatide Easier on the Eyes Than GLP-1s?
Using tirzepatide is linked to lower risks of developing primary open-angle glaucoma and elevated eye pressure in patients with type 2 diabetes than using GLP-1 receptor agonists, a study finds. Medscape Medical News
Infant Hydrocortisone Shows No Developmental Harm Later
Neonatal hydrocortisone vs placebo for premature infants at risk for bronchopulmonary dysplasia shows no benefit or harm and no difference in functional impairment by the time they reach kindergarten. Medscape Medical News
Can a Visual Neuroprosthesis Communicate With the Brain?
A closed-loop cortical implant generates functional percepts of shape, motion, and letters in two individuals with acquired blindness. Medscape News Europe
Med Op-Ed: Climate-Induced Runny Nose, Pesky No-Shows, More
The clinical ramifications of longer pollen seasons; seeing deeper meaning in ‘Did Not Attends’; and scientific advances may soon transform glaucoma care. Medscape Medical News
Childhood Sjögren Disease Tied to Distinct Disease Patterns
Patients with childhood-onset Sjögren disease show distinct trajectories for disease activity and symptoms, with a notable proportion having an increased risk for lymphoma and early glandular damage. Medscape Medical News
AI Could Ease Caregiver Burden for Older Adults, Study Finds
Experts say many AI tools intend to support older adults, but trust, cost, and design gaps could slow adoption. Medscape Medical News
CDC: Women Hospitalized Ater Self-Injecting Botulinum Toxin
As state health departments report more botulism-like illnesses, consumers have easy access to unapproved products and information on how to self-inject. Medscape Medical News
CDC: Women Hospitalized After Self-Injecting Botulinum Toxin
As state health departments report more botulism-like illnesses, consumers have easy access to unapproved products and information on how to self-inject. Medscape Medical News
Pre-filled Syringe Presentation of BYOOVIZ®, Samsung Bioepis' Biosimilar to Lucentis (Ranibizumab), Gains European Approval
INCHEON, Korea–(BUSINESS WIRE)– #amd–Samsung Bioepis’ Byooviz PFS gains European approval.
Warby Parker Announces Participation in the Morgan Stanley Global Consumer & Retail Conference
NEW YORK–(BUSINESS WIRE)–Warby Parker Inc. (NYSE: WRBY) (the “Company”), a direct-to-consumer lifestyle brand focused on vision for all, today announced that the Company will be presenting at the Morgan Stanley Global Consumer & Retail Conference…
Eye Washing Can Help Manage Hay Fever Symptoms
Eye washing is linked to less severe ocular symptoms of hay fever, fewer flares, and more days without symptoms, according to a digital prospective study. Medscape Medical News
BTIG to Host 5th Annual Ophthalmology Day on December 1, 2025
NEW YORK–(BUSINESS WIRE)–BTIG announced today that its 5th Annual Ophthalmology Day will take place on Monday, December 1, 2025. The virtual, one-day event will include thematic panel discussions and one-on-one meetings. The event will be hosted by: …
AGCバイオロジクス、遺伝性網膜疾患向けにAAVantgardeのデュアルベクター遺伝子治療薬を製造へ
ミラン–(BUSINESS WIRE)–（ビジネスワイヤ） — AGCバイオロジクスは、AAVantgardeによるシリーズB資金調達ラウンドの完了直後も、同バイオテクノロジー企業との新たな製造契約を発表しました。これは、アデノ随伴ウイルス市場におけるAGCバイオロジクスの最新の進展となります。本契約の下、同社は、現在承認された治療法が存在せず、進行性かつ不可逆的な視力低下に対応するために設計されたAAVantgardeの2つの新規候補品について、Good Manufacturing Prac…
AGC Biologics produziert die Dual-Vektor-Gentherapien von AAVantgarde für erbliche Netzhauterkrankungen
MAILAND–(BUSINESS WIRE)–Nach dem Abschluss einer Serie-B-Finanzierungsrunde durch AAVantgarde hat AGC Biologics eine neue Produktionsvereinbarung mit dem Biotechnologieunternehmen bekannt gegeben. Damit hat AGC Biologics einen weiteren Meilenstein au…
AGC Biologics produrrà terapie geniche a doppio vettore di AAVantgarde mirate alle retinopatie ereditarie
MILANO–(BUSINESS WIRE)–Dopo la chiusura di un round di finanziamento di serie B da parte di AAVantgarde, AGC Biologics ha annunciato un nuovo accordo di produzione con l’azienda biotech, che rappresenta il progresso più recente di AGC Biologics nel m…
AGC Biologics to Manufacture AAVantgarde’s Dual-Vector Gene Therapies for Inherited Retinal Disorders
MILAN–(BUSINESS WIRE)– #Biotech–On the heels of AAVantgarde closing a Series B financing round, AGC Biologics announced a new manufacturing agreement with the biotechnology company, marking AGC Biologics’ latest advancement in the adeno-associated v…
U.S. FDA Approves HYRNUO® (sevabertinib) for Previously Treated Patients with HER2-Mutated Locally Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
WHIPPANY, N.J.–(BUSINESS WIRE)–U.S. FDA Approves HYRNUO® (sevabertinib) for Previously Treated Patients with HER2-Mutated Locally Advanced or Metastatic Non-Squamous NSCLC